{"DataElement":{"publicId":"6704129","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome AJCC Edition 8 Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastases for mycosis fungoides and sezary syndrome using AJCC Ed. 8 criteria.","longName":"MFSS_AJC8_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6702827","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome M Category","preferredDefinition":"Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood.  Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome. --2003_One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"6702710v1.0:2678077v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6702710","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome","preferredDefinition":"Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood.  Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome. --2003","longName":"C9265","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycosis Fungoides and Sezary Syndrome","conceptCode":"C9265","definition":"Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood.  Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86CE9C6C-F805-26F5-E053-F662850A0B07","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"ONEDATA","dateModified":"2019-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2678077","version":"1","preferredName":"M Stage","preferredDefinition":"One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3978B83D-5D9A-3E76-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-06","endDate":null,"createdBy":"UMLLOADER_COCANUT","dateCreated":"2007-09-06","modifiedBy":"ONEDATA","dateModified":"2007-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86C5266F-58D0-1BC7-E053-F662850A99C4","latestVersionIndicator":"Yes","beginDate":"2019-04-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-18","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":"4-18-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6704088","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome American Joint Committee on Cancer Edition 8 M Category","preferredDefinition":"A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases (visceral). (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6704088v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1","valueDescription":"Mycosis Fungoides and Sezary Syndrome M1 TNM Finding v8","ValueMeaning":{"publicId":"6704090","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome M1 TNM Finding v8","longName":"6704090","preferredDefinition":"Visceral involvement (must have pathology confirmation and organ involved should be specified). Note: for viscera, spleen and liver may be diagnosed by imaging criteria. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycosis Fungoides and Sezary Syndrome M1 TNM Finding v8","conceptCode":"C141308","definition":"Visceral involvement (must have pathology confirmation and organ involved should be specified). Note: for viscera, spleen and liver may be diagnosed by imaging criteria. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E1FCEA-3436-5D5C-E053-F662850AB71C","latestVersionIndicator":"Yes","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86E1FCEA-344F-5D5C-E053-F662850AB71C","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"ONEDATA","dateModified":"2019-04-19","deletedIndicator":"No"},{"value":"M0","valueDescription":"Mycosis Fungoides and Sezary Syndrome M0 TNM Finding v8","ValueMeaning":{"publicId":"6704092","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome M0 TNM Finding v8","longName":"6704092","preferredDefinition":"No visceral organ involvement. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycosis Fungoides and Sezary Syndrome M0 TNM Finding v8","conceptCode":"C141307","definition":"No visceral organ involvement. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E1FCEA-345C-5D5C-E053-F662850AB71C","latestVersionIndicator":"Yes","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86E1FCEA-3475-5D5C-E053-F662850AB71C","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"ONEDATA","dateModified":"2019-04-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6704087","version":"1","preferredName":"Mycosis Fungoides and Sezary Syndrome Distant Metastasis TNM Finding v8 American Joint Committee on Cancer M Category Category","preferredDefinition":"A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases (visceral). (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C141306:C39315:C25727:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycosis Fungoides and Sezary Syndrome Distant Metastasis TNM Finding v8","conceptCode":"C141306","definition":"A finding about one or more characteristics of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases (visceral). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E1FCEA-3409-5D5C-E053-F662850AB71C","latestVersionIndicator":"Yes","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"ONEDATA","dateModified":"2019-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"86E1FCEA-341A-5D5C-E053-F662850AB71C","latestVersionIndicator":"Yes","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":"4-19-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6702791","version":"1","longName":"Mycosis Fungoides and Sezary Syndrome","context":"NCI Standards"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"C3D Question Text","type":"Alternate Question Text","description":"Visceral","url":null,"context":"CCR"},{"name":"M category","type":"Preferred Question Text","description":"M category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"86E2D88A-15B7-66D8-E053-F662850A3E65","latestVersionIndicator":"Yes","beginDate":"2019-04-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-19","modifiedBy":"COOPERM","dateModified":"2019-04-25","changeDescription":"4-19-19 created for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}